Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease.

Authors
Type
Published Article
Journal
Blood
1528-0020
Publisher
American Society of Hematology
Publication Date
Volume
116
Issue
18
Pages
3627–3634
Identifiers
DOI: 10.1182/blood-2010-03-271791
PMID: 20644113
Source
Medline

Abstract

Statistics

Seen <100 times